T2 Biosystems slips after downbeat Q2 prelim revenue

T2 Biosystems

12/07/2023 14:18

** Shares of in-vitro diagnostics company T2 Biosystems Inc
 TTOO.O  fall 10.9% to 13 cents before the bell
    ** Company, which provides rapid detection testing for
sepsis-causing pathogens, reports prelim Q2 revenue of $2 mln,
below analysts' avg. est. of $2.7 mln - Refinitiv
    ** TTOO sees FY23 total sepsis-detecting and related product
revenue of $9.5 mln to $10.5 mln
    ** As of last close, stock down 89.44% YTD

 (Reporting by Pratik Jain in Bengaluru)
 ((Pratik.Jain@thomsonreuters.com;))